Brooks Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

26.25

24.70

24.70

24.70

24.70

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

43.28

32.08

40.30

39.51

73.71

Loan funds

Secured loans

5.04

5.66

4.92

8.16

24.01

Unsecured loans

-

-

-

-

-

Total

74.57

62.44

69.93

72.37

122.43

Uses of funds

Fixed assets

Gross block

22.62

21.82

20.66

19.70

132.46

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

8.95

6.81

5.53

4.74

19.43

Net block

13.67

15.01

15.14

14.96

113.02

Capital work-in-progress

-

-

1.12

0.02

0.11

Investments

46.86

46.85

46.84

46.81

0.02

Net current assets

Current assets, loans & advances

33.86

30.56

40.35

31.21

44.71

Less : current liabilities & provisions

19.82

29.98

33.53

20.62

35.44

Total net current assets

14.04

0.58

6.82

10.59

9.27

Miscellaneous expenses not written

-

-

-

-

-

Total

74.57

62.44

69.93

72.37

122.43

Notes:

Book value of unquoted investments

46.86

46.85

46.84

46.81

0.02

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

72.29

20.84

24.79

29.70

25.77

Number of equity sharesoutstanding (Lacs)

262.47

247.03

247.03

247.03

247.03